glp 1 agonist trials Orforglipron, an Oral Small-Molecule GLP-1 Receptor for Obesity Treatment In the original clinical trials
Description
Keywords: GIP, GLP-1, GLP-1RA, tirzepatide, diabetes, obesity, cardiovascular disease 1
Our study also had some limitations
[DOI] [PubMed] [Google Scholar] 128.Hinke SA, Gelling RW, Pederson RA, Manhart S, Nian C, et al
To address this, we employed a shared-parameter approach combined with a single-arm meta-analysis and Bayesian feedback to estimate these values
32260-8/asset/b3e92579-8c29-4267-895b-56d26c1d4c0b/main.assets/gr3_lrg.jpg)
doi: 10.1172/JCI146353
However, heterogeneity in weight loss response, cost, side effects, and need for injections may limit their use in many pediatric patients [23]
